Literature DB >> 9733860

Purification and characterization of a cellular protein that binds to the downstream activation sequence of the strict late UL38 promoter of herpes simplex virus type 1.

M D Petroski1, E K Wagner.   

Abstract

Previous work on the strict late (gamma) UL38 promoter of herpes simplex virus type 1 identified three cis-acting elements required for wild-type levels of transcription: a TATA box at -31, a consensus mammalian initiator element at the transcription start site, and a downstream activation sequence (DAS) at +20 to +33. DAS is found in similar locations on several other late promoters, suggesting an important regulatory role in late gene expression. In this communication, we further characterize the interaction between DAS and a cellular protein which is found in both uninfected and infected nuclear extracts. This protein was purified from HeLa nuclear extracts and identified as the DNA binding component (Ku heterodimer) of DNA-dependent protein kinase (DNA-PK) by peptide mapping. Highly purified DNA-PK was able to stimulate UL38 transcription in vitro approximately 10-fold. DAS is similar in sequence to another element, nuclear regulatory element 1 (NRE1) of the glucocorticoid-responsive mouse mammary tumor virus long terminal repeat. NRE1 is known to specifically bind Ku in the absence of DNA ends. We demonstrated that NRE1 is able to substitute for DAS in the UL38 promoter to activate transcription as measured by in vitro transcription and in vivo during infection of tissue culture cells with recombinant virus. Also, we found that the binding of DNA-PK to DAS involves the bases demonstrated to be important in UL38 transcription and that the 70-kDa subunit of Ku binds to DAS.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9733860      PMCID: PMC110164     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Herpes simplex virus recombination vectors designed to allow insertion of modified promoters into transcriptionally "neutral" segments of the viral genome.

Authors:  J Singh; E K Wagner
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

2.  Drosophila TFIID binds to a conserved downstream basal promoter element that is present in many TATA-box-deficient promoters.

Authors:  T W Burke; J T Kadonaga
Journal:  Genes Dev       Date:  1996-03-15       Impact factor: 11.361

Review 3.  Transcription of the herpes simplex virus genome during productive and latent infection.

Authors:  E K Wagner; J F Guzowski; J Singh
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1995

4.  Transcriptional activation of the herpes simplex virus type 1 UL38 promoter conferred by the cis-acting downstream activation sequence is mediated by a cellular transcription factor.

Authors:  J F Guzowski; J Singh; E K Wagner
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

5.  Herpes simplex virus inhibits host cell splicing, and regulatory protein ICP27 is required for this effect.

Authors:  W R Hardy; R M Sandri-Goldin
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

6.  Evaluation of colocalization interactions between the IE110, IE175, and IE63 transactivator proteins of herpes simplex virus within subcellular punctate structures.

Authors:  M A Mullen; S Gerstberger; D M Ciufo; J D Mosca; G S Hayward
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

7.  Modification of discrete nuclear domains induced by herpes simplex virus type 1 immediate early gene 1 product (ICP0).

Authors:  G G Maul; H H Guldner; J G Spivack
Journal:  J Gen Virol       Date:  1993-12       Impact factor: 3.891

8.  A DNA-binding activity, TRAC, specific for the TRA element of the transferrin receptor gene copurifies with the Ku autoantigen.

Authors:  M R Roberts; Y Han; A Fienberg; L Hunihan; F H Ruddle
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

9.  Nuclear domain 10 as preexisting potential replication start sites of herpes simplex virus type-1.

Authors:  G G Maul; A M Ishov; R D Everett
Journal:  Virology       Date:  1996-03-01       Impact factor: 3.616

10.  Purification of the sequence-specific transcription factor CTCBF, involved in the control of human collagen IV genes: subunits with homology to Ku antigen.

Authors:  E Genersch; C Eckerskorn; F Lottspeich; C Herzog; K Kühn; E Pöschl
Journal:  EMBO J       Date:  1995-02-15       Impact factor: 11.598

View more
  6 in total

1.  Global analysis of herpes simplex virus type 1 transcription using an oligonucleotide-based DNA microarray.

Authors:  S W Stingley; J J Ramirez; S A Aguilar; K Simmen; R M Sandri-Goldin; P Ghazal; E K Wagner
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  A human cellular protein activity (OF-1), which binds herpes simplex virus type 1 origin, contains the Ku70/Ku80 heterodimer.

Authors:  Lauren B Murata; Mark S Dodson; Jennifer D Hall
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

3.  Ku antigen-DNA conformation determines the activation of DNA-dependent protein kinase and DNA sequence-directed repression of mouse mammary tumor virus transcription.

Authors:  W Giffin; W Gong; C Schild-Poulter; R J Haché
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

4.  The downstream activation sequence of the strict late Herpes Simplex Virus Type 1 U(L)38 promoter interacts with hTAF(II)70, a component of TFIID.

Authors:  M D Petroski; G B Devi-Rao; M K Rice; E K Wagner
Journal:  Virus Genes       Date:  2001-06       Impact factor: 2.332

5.  Proteomics of herpes simplex virus replication compartments: association of cellular DNA replication, repair, recombination, and chromatin remodeling proteins with ICP8.

Authors:  Travis J Taylor; David M Knipe
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

6.  Requirement of a 12-base-pair TATT-containing sequence and viral lytic DNA replication in activation of the Kaposi's sarcoma-associated herpesvirus K8.1 late promoter.

Authors:  Shuang Tang; Koji Yamanegi; Zhi-Ming Zheng
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.